EFS and OS of patients who achieved a hematologic CR (n = 145) after HDM/SCT compared with those who did not (non-CR, n = 195). EFS was significantly longer for CR patients (8.3 vs 2 years, P < .0001), as was OS (13.2 vs 5.9 years, P < .0001).